Skip to main content
. 2015 Jun 29;10(6):e0131595. doi: 10.1371/journal.pone.0131595

Fig 4. Representative immunohistochemistry (left) and prevalence (right) of insulin staining in control versus MSG-treated groups at 1, 3, 6, and 9 months (x400).

Fig 4

* P<0.05.